Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:58775074:4752 |
Source | marc_columbia |
Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:58775074:4752?format=raw |
LEADER: 04752fam a2200373 a 4500
001 4052071
005 20221027024822.0
008 960419t19961996flua b 001 0 eng c
010 $a 96002799
020 $a0849394236 (alk. paper)
035 $a(OCoLC)34674928
035 $a(OCoLC)ocm34674928
035 $9ALR0274HS
035 $a(NNC)4052071
035 $a4052071
040 $aDNLM/DLC$cDLC$dDLC$dNNC-M$dOrLoB-B
050 00 $aRC600$b.A79 1996
060 10 $aWD 305 A633 1996
082 00 $a616.07$220
245 04 $aThe antiphospholipid syndrome /$cedited by Ronald A. Asherson [and others].
260 $aBoca Raton :$bCRC Press,$c[1996], ©1996.
300 $a339 pages :$billustrations (some color) ;$c26 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $gCh. 1.$tThe Antiphospholipid Syndrome: History, Definition, Classification, and Differential Diagnosis /$rRonald A. Asherson, Ricard Cervera, Jean-Charles Piette and Yehuda Shoenfeld --$gCh. 2.$tEpidemiology of the Antiphospholipid Syndrome /$rMichelle Petri --$gCh. 3.$tImmunology and Methods of Detection of the Antiphospholipid Antibodies /$rDavid A. Kandiah and Steven A. Krilis --$gCh. 4.$tImmunogenetics of the Antiphospholipid Syndrome /$rGian Domenico Sebastiani and Mauro Galeazzi --$gCh. 5.$tPathogenesis of the Antiphospholipid Syndrome /$rRonit Bakimer and Yehuda Shoenfeld --$gCh. 6.$tAnimal Models of the Antiphospholipid Syndrome /$rAngela Tincani and Yehuda Shoenfeld --$gCh. 7.$tCytokines in the Antiphospholipid Syndrome /$rPnina Fishman and Yehuda Shoenfeld --$gCh. 8.$tPathology of the Antiphospholipid Syndrome /$rJ. T. Lie --$gCh. 9.$tThrombotic Manifestations in the Antiphospholipid Syndrome /$rJosep Ordi-Ros, Alberto Selva-O'Callaghan and Miquel Vilardell-Tarres --
505 80 $gCh. 10.$tFetal Losses and Other Obstetric Manifestations in the Antiphospholipid Syndrome /$rCarolyn M. Salafia, Kathryn A. Starzyk, Jose Lopez-Zeno and Ann Parke --$gCh. 11.$tCerebral Thrombosis and Other Neurologic Manifestations in the Antiphospholipid Syndrome /$rRobin Brey, Agustin Escalante, Nancy Futrell and Ronald A. Asherson --$gCh. 12.$tCardiac Manifestations in the Antiphospholipid Syndrome /$rRicard Cervera, Josep Font and Miguel Ingelmo --$gCh. 13.$tPulmonary Manifestations in the Antiphospholipid Syndrome /$rRicard Cervera, Mario Garcia-Carrasco and Ronald A. Asherson --$gCh. 14.$tRenal Manifestations in the Antiphospholipid Syndrome /$rJean-Charles Piett, Dieter Kleinknecht and Jean Francois Bach --$gCh. 15.$tAdrenal, Hepatic, and Other Intraabdominal Manifestations in the Antiphospholipid Syndrome /$rRonald A. Asherson --$gCh. 16.$tOsteoarticular Manifestations in the Antiphospholipid Syndrome /$rFrederic Liote and Olivier Meyer --
505 80 $gCh. 17.$tDermatologic Manifestations in the Antiphospholipid Syndrome /$rCamille Frances, Olivier Bletry and Jean-Charles Piette --$gCh. 18.$tOphthalmic Manifestations in the Antiphospholipid Syndrome /$rRobert J. Labutta --$gCh. 19.$tThrombocytopenia and Other Hematological Abnormalities in the Antiphospholipid Syndrome /$rKevin A. Davies, P. Athanassiou and Sozos A. Loizou --$gCh. 20.$tImmunologic Abnormalities in the Antiphospholipid Syndrome /$rPier Luigi Meroni, Angela Tincani, Laura Spatola, Luigi La Rosa and Genesio Balestrieri --$gCh. 21.$t"Primary," "Secondary," "Catastrophic," and Other Variants of the Antiphospholipid Syndrome /$rRonald A. Asherson, Jean-Charles Piette and Ricard Cervera --$gCh. 22.$tPediatric and Familial Antiphospholipid Syndromes /$rLisa R. Sammaritano --$gCh. 23.$tThe Antiphosholipid Syndrome in Infectious Diseases /$rSozos A. Loizou, Mark J. Walport and Kevin A. Davies --
505 80 $gCh. 24.$tManagement of Venous and Arterial Thrombosis in the Antiphospholipid Syndrome /$rRonald H. W. M. Derksen and Philip G. de Groot --$gCh. 25.$tProphylaxis of Fetal Losses in the Antiphospholipid Syndrome /$rJuan Balasch and Josep Font --$gCh. 26.$tOther Aspects of the Management of the Antiphospholipid Syndrome /$rJean-Charles Piette and Bertrand Wechsler --$gCh. 27.$tCourse and Prognosis of the Antiphospholipid Syndrome /$rDonato Alarcon-Segovia and Cristina Drenkard --$gCh. 28.$tNew Perspectives in the Study and Treatment of the Antiphospholipid Syndrome /$rMichael Lockshin.
650 0 $aAntiphospholipid syndrome.$0http://id.loc.gov/authorities/subjects/sh96004785
650 12 $aAntiphospholipid Syndrome.$0https://id.nlm.nih.gov/mesh/D016736
650 22 $aAntibodies, Antiphospholipid.$0https://id.nlm.nih.gov/mesh/D017152
700 1 $aAsherson, Ronald A.$0http://id.loc.gov/authorities/names/n87894752
852 00 $boff,hsl$hRC600$i.A79 1996